A norovirus vaccine could save 900 lives a year and prevent 109,000 hospital admissions, 465,000 emergency room visits and 2.27 million urgent care visits, Oxford University Press reports for the Infectious Diseases Society of America.
Health care cost savings from a norovirus vaccine would run between $430 and $740 million
Continue Reading A norovirus vaccine would save hundreds of lives and millions of dollars
A vaccine for the world’s most common cause of acute gastroenteritis and the USA’s most common cause of foodborne illness is now in human clinical trials. The trial by Japan’s Takeda Pharmaceutical Co. Ltd. involves the first norovirus vaccine prospect to enter human adult or efficacy trials. Rob Goodwin, vice
Continue Reading Takeda’s norovirus vaccine first to reach human trials
If you’ve ever suffered through food poisoning, odds are that the bug you caught was norovirus, the most common foodborne illness in the world. Just in the United States, norovirus causes an annual estimated 19 to 21 million illnesses and contributes to 56,000 to 71,000 hospitalizations and 570 to 800
Continue Reading Could a Norovirus Vaccine Become Reality?
